Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Pitt

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|July 15, 2016
Addenbrooke's reunionJane Pitt
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2003
Zidovudine resistance phenotype and risk of perinatal HIV-1 transmission in zidovudine monotherapy-treated mothers with moderately advanced diseaseGreta R Bauer, Seth L Welles, Robert R Colgrove, et al.
AIDS Research and Human Retroviruses|March 30, 2005
Gag-p6 Tsg101 binding site duplications in maternal-infant HIV infectionRobert C Colgrove, Amy Millet, Greta R Bauer, et al.
AIDS (London, England)|August 26, 2006
Antiretroviral resistance in viral isolates from HIV-1-transmitting mothers and their infantsGreta R Bauer, Robert C Colgrove, Philip S Larussa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2006
Time trends for HIV-1 antiretroviral resistance among antiretroviral-experienced and naive pregnant women in New York City during 1991 to early 2001Seth L Welles, Greta R Bauer, Philip S LaRussa, et al.
The Journal of Infectious Diseases|June 27, 2002
Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathyHal B Jenson, Charles J Gauntt, Kirk A Easley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancyRuth E Tuomala, D Heather Watts, Daner Li, et al.
Pediatrics|May 4, 2004
Immune parameters and morbidity in hard drug and human immunodeficiency virus-exposed but uninfected infantsNatalie Neu, Robert Leighty, Samuel Adeniyi-Jones, et al.
AIDS (London, England)|October 3, 2003
Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected childrenStuart E Starr, Elizabeth J McFarland, Petronella Muresan, et al.
The Pediatric Infectious Disease Journal|June 4, 2005
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of lifeAndrea Kovacs, Mary Kathryn Cowles, Paula Britto, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|July 15, 2016
Addenbrooke's reunionJane Pitt
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2003
Zidovudine resistance phenotype and risk of perinatal HIV-1 transmission in zidovudine monotherapy-treated mothers with moderately advanced diseaseGreta R Bauer, Seth L Welles, Robert R Colgrove, et al.
AIDS Research and Human Retroviruses|March 30, 2005
Gag-p6 Tsg101 binding site duplications in maternal-infant HIV infectionRobert C Colgrove, Amy Millet, Greta R Bauer, et al.
AIDS (London, England)|August 26, 2006
Antiretroviral resistance in viral isolates from HIV-1-transmitting mothers and their infantsGreta R Bauer, Robert C Colgrove, Philip S Larussa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2006
Time trends for HIV-1 antiretroviral resistance among antiretroviral-experienced and naive pregnant women in New York City during 1991 to early 2001Seth L Welles, Greta R Bauer, Philip S LaRussa, et al.
The Journal of Infectious Diseases|June 27, 2002
Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathyHal B Jenson, Charles J Gauntt, Kirk A Easley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancyRuth E Tuomala, D Heather Watts, Daner Li, et al.
Pediatrics|May 4, 2004
Immune parameters and morbidity in hard drug and human immunodeficiency virus-exposed but uninfected infantsNatalie Neu, Robert Leighty, Samuel Adeniyi-Jones, et al.
AIDS (London, England)|October 3, 2003
Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected childrenStuart E Starr, Elizabeth J McFarland, Petronella Muresan, et al.
The Pediatric Infectious Disease Journal|June 4, 2005
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of lifeAndrea Kovacs, Mary Kathryn Cowles, Paula Britto, et al.
Pageof 2